StemoniX Competitors and Similar CompaniesClear all

StemoniX's competitors and similar companies include Medicalsystem Biotechnology, IntegraGen, Prexton Therapeutics and Coyote Bioscience.
StemoniX
StemoniX
StemoniX is a biotech company that engages in the production and development of stem cell.
Medicalsystem Biotechnology
Medicalsystem Biotechnology
Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.
IntegraGen
IntegraGen
IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.
Prexton Therapeutics
Prexton Therapeutics
Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioural and chemistry technologies to address Parkinson’s disease and other brain disorders.
Coyote Bioscience
Coyote Bioscience
Coyote Bioscience is a company that offers molecular diagnostics solutions, pathogen detection, and life science tools by providing devices and consumables.
Founding Date
Founding Date
2014
Founding Date
2003
Founding Date
2000
Founding Date
2012
Founding Date
N/A
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Osseo, US HQ
Locations
Ningbo Shi, CN HQ
Locations
Évry, FR HQ
Cambridge, US
Locations
Oss, NL HQ
Plan Les Ouates, CH
Locations
Beijing, CN HQ
Beijing, CN
Wuxi, CN
Istanbul, TR
Campbell, US
Employees
Employees
1
Employees
2,104
Employees
4420% decrease
Employees
1
Employees
39
Valuation ($)
Valuation ($)
N/A
Valuation ($)
578.8 m
Valuation ($)
3.8 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥1.7b (FY, 2024)
Revenue (est.)
€5m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
¥966.1m (FY, 2024)
Cost of goods
€1.8m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
¥761m (FY, 2024)
Gross profit
€3.5m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
¥262.7m (FY, 2024)
Net income
(€2.7m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 26.1m
Total funding raised
N/A
Total funding raised
$ 14.3m
Total funding raised
$ 41.1m
Total funding raised
$ 91.6m
For sources of this data, please see the company profile

View Company Profiles

Medicalsystem Biotechnology
HQ
Ningbo Shi, CN
Employees
2,104

Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.

View company
IntegraGen
HQ
Évry, FR
Employees
44↓ 20% decrease

IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.

View company
Prexton Therapeutics
HQ
Oss, NL

Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioural and chemistry technologies to address Parkinson’s disease and other brain disorders.

View company
Coyote Bioscience
HQ
Beijing, CN
Employees
39

Coyote Bioscience is a company that offers molecular diagnostics solutions, pathogen detection, and life science tools by providing devices and consumables.

View company